Using nuclear lysates from isogenic glioblastoma lines with intact or mutant STAG2, Kim et al. found that a truncating STAG2 mutation also reduced interaction of the core complex with WAPL/PDS5A/5B [117]. The gene discussed is STAG2; the disease is glioblastoma.